Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism

Ke Jie Yin, John R. Cirrito, Ping Yan, Xiaoyan Hu, Qingli Xiao, Xiaoou Pan, Randall Bateman, Haowei Song, Fong Fu Hsu, John Turk, Jan Xu, Chung Y. Hsu, Jason C. Mills, David M. Holtzman, Jin Moo Lee

Research output: Contribution to journalArticle

205 Citations (Scopus)

Abstract

It has been postulated that the development of amyloid plaques in Alzheimer's disease (AD) may result from an imbalance between the generation and clearance of the amyloid-β peptide (Aβ). Although familial AD appears to be caused by Aβ overproduction, sporadic AD (the most prevalent form) may result from impairment in clearance. Recent evidence suggests that several proteases may contribute to the degradation of Aβ. Furthermore, astrocytes have recently been implicated as a potential cellular mediator of Aβ degradation. In this study, we examined the possibility that matrix metalloproteinases (MMPs), proteases known to be expressed and secreted by astrocytes, could play a role in extracellular Aβ degradation. We found that astrocytes surrounding amyloid plaques showed enhanced expression of MMP-2 and MMP-9 in aged amyloid precursor protein (APP)/presenilin 1 mice. Moreover, astrocyte-conditioned medium (ACM) degraded Aβ, lowering levels and producing several fragments after incubation with synthetic human Aβ1-40 and Aβ1-42. This activity was attenuated with specific inhibitors of MMP-2 and -9, as well as in ACM derived from mmp-2 or -9 knock-out (KO) mice. In vivo, significant increases in the steady-state levels of Aβ were found in the brains of mmp-2 and -9 KO mice compared with wild-type controls. Furthermore, pharmacological inhibition of the MMPs with N-[(2R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl]-L-tryptophan methylamide (GM 6001) increased brain interstitial fluid Aβ levels and elimination of half-life in APPsw mice. These results suggest that MMP-2 and -9 may contribute to extracellular brain Aβ clearance by promoting Aβ catabolism.

Original languageEnglish
Pages (from-to)10939-10948
Number of pages10
JournalJournal of Neuroscience
Volume26
Issue number43
DOIs
Publication statusPublished - Oct 25 2006

Fingerprint

Matrix Metalloproteinases
Amyloid
Astrocytes
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9
Peptides
Alzheimer Disease
Amyloid Plaques
Conditioned Culture Medium
Knockout Mice
Brain
Peptide Hydrolases
Amyloid beta-Protein Precursor
Extracellular Fluid
Tryptophan
Half-Life
Pharmacology

Keywords

  • Alzheimer's disease
  • Amyloid β clearance
  • Astrocytes
  • Laser-capture microdissection
  • Matrix metalloproteinases
  • Microdialysis

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism. / Yin, Ke Jie; Cirrito, John R.; Yan, Ping; Hu, Xiaoyan; Xiao, Qingli; Pan, Xiaoou; Bateman, Randall; Song, Haowei; Hsu, Fong Fu; Turk, John; Xu, Jan; Hsu, Chung Y.; Mills, Jason C.; Holtzman, David M.; Lee, Jin Moo.

In: Journal of Neuroscience, Vol. 26, No. 43, 25.10.2006, p. 10939-10948.

Research output: Contribution to journalArticle

Yin, KJ, Cirrito, JR, Yan, P, Hu, X, Xiao, Q, Pan, X, Bateman, R, Song, H, Hsu, FF, Turk, J, Xu, J, Hsu, CY, Mills, JC, Holtzman, DM & Lee, JM 2006, 'Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism', Journal of Neuroscience, vol. 26, no. 43, pp. 10939-10948. https://doi.org/10.1523/JNEUROSCI.2085-06.2006
Yin, Ke Jie ; Cirrito, John R. ; Yan, Ping ; Hu, Xiaoyan ; Xiao, Qingli ; Pan, Xiaoou ; Bateman, Randall ; Song, Haowei ; Hsu, Fong Fu ; Turk, John ; Xu, Jan ; Hsu, Chung Y. ; Mills, Jason C. ; Holtzman, David M. ; Lee, Jin Moo. / Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism. In: Journal of Neuroscience. 2006 ; Vol. 26, No. 43. pp. 10939-10948.
@article{048fd5ead7a2466f9b0e3c6ed03cf9e7,
title = "Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism",
abstract = "It has been postulated that the development of amyloid plaques in Alzheimer's disease (AD) may result from an imbalance between the generation and clearance of the amyloid-β peptide (Aβ). Although familial AD appears to be caused by Aβ overproduction, sporadic AD (the most prevalent form) may result from impairment in clearance. Recent evidence suggests that several proteases may contribute to the degradation of Aβ. Furthermore, astrocytes have recently been implicated as a potential cellular mediator of Aβ degradation. In this study, we examined the possibility that matrix metalloproteinases (MMPs), proteases known to be expressed and secreted by astrocytes, could play a role in extracellular Aβ degradation. We found that astrocytes surrounding amyloid plaques showed enhanced expression of MMP-2 and MMP-9 in aged amyloid precursor protein (APP)/presenilin 1 mice. Moreover, astrocyte-conditioned medium (ACM) degraded Aβ, lowering levels and producing several fragments after incubation with synthetic human Aβ1-40 and Aβ1-42. This activity was attenuated with specific inhibitors of MMP-2 and -9, as well as in ACM derived from mmp-2 or -9 knock-out (KO) mice. In vivo, significant increases in the steady-state levels of Aβ were found in the brains of mmp-2 and -9 KO mice compared with wild-type controls. Furthermore, pharmacological inhibition of the MMPs with N-[(2R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl]-L-tryptophan methylamide (GM 6001) increased brain interstitial fluid Aβ levels and elimination of half-life in APPsw mice. These results suggest that MMP-2 and -9 may contribute to extracellular brain Aβ clearance by promoting Aβ catabolism.",
keywords = "Alzheimer's disease, Amyloid β clearance, Astrocytes, Laser-capture microdissection, Matrix metalloproteinases, Microdialysis",
author = "Yin, {Ke Jie} and Cirrito, {John R.} and Ping Yan and Xiaoyan Hu and Qingli Xiao and Xiaoou Pan and Randall Bateman and Haowei Song and Hsu, {Fong Fu} and John Turk and Jan Xu and Hsu, {Chung Y.} and Mills, {Jason C.} and Holtzman, {David M.} and Lee, {Jin Moo}",
year = "2006",
month = "10",
day = "25",
doi = "10.1523/JNEUROSCI.2085-06.2006",
language = "English",
volume = "26",
pages = "10939--10948",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "43",

}

TY - JOUR

T1 - Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism

AU - Yin, Ke Jie

AU - Cirrito, John R.

AU - Yan, Ping

AU - Hu, Xiaoyan

AU - Xiao, Qingli

AU - Pan, Xiaoou

AU - Bateman, Randall

AU - Song, Haowei

AU - Hsu, Fong Fu

AU - Turk, John

AU - Xu, Jan

AU - Hsu, Chung Y.

AU - Mills, Jason C.

AU - Holtzman, David M.

AU - Lee, Jin Moo

PY - 2006/10/25

Y1 - 2006/10/25

N2 - It has been postulated that the development of amyloid plaques in Alzheimer's disease (AD) may result from an imbalance between the generation and clearance of the amyloid-β peptide (Aβ). Although familial AD appears to be caused by Aβ overproduction, sporadic AD (the most prevalent form) may result from impairment in clearance. Recent evidence suggests that several proteases may contribute to the degradation of Aβ. Furthermore, astrocytes have recently been implicated as a potential cellular mediator of Aβ degradation. In this study, we examined the possibility that matrix metalloproteinases (MMPs), proteases known to be expressed and secreted by astrocytes, could play a role in extracellular Aβ degradation. We found that astrocytes surrounding amyloid plaques showed enhanced expression of MMP-2 and MMP-9 in aged amyloid precursor protein (APP)/presenilin 1 mice. Moreover, astrocyte-conditioned medium (ACM) degraded Aβ, lowering levels and producing several fragments after incubation with synthetic human Aβ1-40 and Aβ1-42. This activity was attenuated with specific inhibitors of MMP-2 and -9, as well as in ACM derived from mmp-2 or -9 knock-out (KO) mice. In vivo, significant increases in the steady-state levels of Aβ were found in the brains of mmp-2 and -9 KO mice compared with wild-type controls. Furthermore, pharmacological inhibition of the MMPs with N-[(2R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl]-L-tryptophan methylamide (GM 6001) increased brain interstitial fluid Aβ levels and elimination of half-life in APPsw mice. These results suggest that MMP-2 and -9 may contribute to extracellular brain Aβ clearance by promoting Aβ catabolism.

AB - It has been postulated that the development of amyloid plaques in Alzheimer's disease (AD) may result from an imbalance between the generation and clearance of the amyloid-β peptide (Aβ). Although familial AD appears to be caused by Aβ overproduction, sporadic AD (the most prevalent form) may result from impairment in clearance. Recent evidence suggests that several proteases may contribute to the degradation of Aβ. Furthermore, astrocytes have recently been implicated as a potential cellular mediator of Aβ degradation. In this study, we examined the possibility that matrix metalloproteinases (MMPs), proteases known to be expressed and secreted by astrocytes, could play a role in extracellular Aβ degradation. We found that astrocytes surrounding amyloid plaques showed enhanced expression of MMP-2 and MMP-9 in aged amyloid precursor protein (APP)/presenilin 1 mice. Moreover, astrocyte-conditioned medium (ACM) degraded Aβ, lowering levels and producing several fragments after incubation with synthetic human Aβ1-40 and Aβ1-42. This activity was attenuated with specific inhibitors of MMP-2 and -9, as well as in ACM derived from mmp-2 or -9 knock-out (KO) mice. In vivo, significant increases in the steady-state levels of Aβ were found in the brains of mmp-2 and -9 KO mice compared with wild-type controls. Furthermore, pharmacological inhibition of the MMPs with N-[(2R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl]-L-tryptophan methylamide (GM 6001) increased brain interstitial fluid Aβ levels and elimination of half-life in APPsw mice. These results suggest that MMP-2 and -9 may contribute to extracellular brain Aβ clearance by promoting Aβ catabolism.

KW - Alzheimer's disease

KW - Amyloid β clearance

KW - Astrocytes

KW - Laser-capture microdissection

KW - Matrix metalloproteinases

KW - Microdialysis

UR - http://www.scopus.com/inward/record.url?scp=33751112725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751112725&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.2085-06.2006

DO - 10.1523/JNEUROSCI.2085-06.2006

M3 - Article

C2 - 17065436

AN - SCOPUS:33751112725

VL - 26

SP - 10939

EP - 10948

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 43

ER -